https://www.bbc.com/news/health-56616119
"The MHRA said it had received 22 reports of cerebral venous sinus thrombosis (CVST) - where a blood clot forms in the brain - and eight reports of "other thrombosis events with low platelets [the cells involved in clotting]" following use of the Oxford-AstraZeneca jab, out of a total of 18.1 million doses given up to and including 24 March
(...)
Meanwhile, the MHRA said there had been no reports of blood clots following use of the Pfizer-BioNTech vaccine.
As of 21 March, an estimated 10.8 million first doses of the Pfizer-BioNTech jab had been administered in the UK, the regulator said."
The blood clot stories hitting the headlines are doing a disservice. If one out of a million of something happens, the human cognitive bias will make it feel like it's likelier than it is.
.. or do Europeans prefer to be locked down for the rest of their lives?
People should ignore the news media and take the vaccine for God's sake, it hasn't killed 40% of the UK, has it ?
"German regulators said they had received 31 reports of rare blood clots in the head in recipients of the AstraZeneca vaccine and nine deaths up to March 29, roughly doubling
Cooke said the EMA will include the Germany cases in its review "and they will form part of the ongoing evaluation that the committee is undertaking, as will any additional cases that are reported from other countries and regions.”
Based on the numbers reported to the agency so far, there have been 4.8 cases of the rare blood clots per million doses of the AstraZeneca vaccine administered, she said."
(https://www.france24.com/en/europe/20210331-eu-says-no-evide...)
The key word is "so far", the article explains that Germany saw the number double since the reporting.
https://www.ft.com/content/d5cd63c6-af01-4d29-a5e5-b69ade4f3...
Reports it as 10x the normal occurence of 3 per 100k. (and I assume that's before doing further slicing, probably slicing for younger women would show even more impact?).
I'm all for vaccine but it's a tight rope to have a successful rollout in EU: https://www.theatlantic.com/health/archive/2021/03/astrazene...
Maybe they could consider reserving the non-AZ doses to the most likely to be affected demographic.
(personally I'm lucky enough to be in a country that's not planning on using the AZ vaccine so there's no question, but rest of EU is different)